0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Foot and Mouth Disease Vaccines Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-26O7183
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Foot and Mouth Disease Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Global Foot and Mouth Disease Vaccines Market Research Report 2025

Code: QYRE-Auto-26O7183
Report
August 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Foot and Mouth Disease Vaccines Market Size

The global market for Foot and Mouth Disease Vaccines was valued at US$ 1125 million in the year 2024 and is projected to reach a revised size of US$ 1436 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Foot and Mouth Disease Vaccines Market

Foot and Mouth Disease Vaccines Market

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.
Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.
Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.
In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Foot and Mouth Disease Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Foot and Mouth Disease Vaccines.
The Foot and Mouth Disease Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Foot and Mouth Disease Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Foot and Mouth Disease Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Foot and Mouth Disease Vaccines Market Report

Report Metric Details
Report Name Foot and Mouth Disease Vaccines Market
Accounted market size in year US$ 1125 million
Forecasted market size in 2031 US$ 1436 million
CAGR 3.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Emergency Vaccines
  • Conventional Vaccines
Segment by Application
  • Cattle
  • Pig
  • Sheep & Goat
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Jinyu Group, Cavet Bio, CAHIC, Tecon Group, Shen Lian, Biogenesis Bago, BIGVET Biotech, Indian Immunologicals, Boehringer Ingelheim, MSD Animal Health, CEVA, Bayer HealthCare, VECOL, Sanofi (Merial), Brilliant Bio Pharma, VETAL, BVI, LIMOR, ME VAC, Agrovet
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Foot and Mouth Disease Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Foot and Mouth Disease Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Foot and Mouth Disease Vaccines Market growing?

Ans: The Foot and Mouth Disease Vaccines Market witnessing a CAGR of 3.6% during the forecast period 2025-2031.

What is the Foot and Mouth Disease Vaccines Market size in 2031?

Ans: The Foot and Mouth Disease Vaccines Market size in 2031 will be US$ 1436 million.

What is the market share of major companies in Foot and Mouth Disease Vaccines Market?

Ans: Global top four manufacturers hold a share nearly 60%.

What is the Foot and Mouth Disease Vaccines Market share by region?

Ans: Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.

What is the Foot and Mouth Disease Vaccines Market share by type?

Ans: In terms of product, Conventional Vaccines is the largest segment, with a share about 70%.

Who are the main players in the Foot and Mouth Disease Vaccines Market report?

Ans: The main players in the Foot and Mouth Disease Vaccines Market are Jinyu Group, Cavet Bio, CAHIC, Tecon Group, Shen Lian, Biogenesis Bago, BIGVET Biotech, Indian Immunologicals, Boehringer Ingelheim, MSD Animal Health, CEVA, Bayer HealthCare, VECOL, Sanofi (Merial), Brilliant Bio Pharma, VETAL, BVI, LIMOR, ME VAC, Agrovet

What are the Application segmentation covered in the Foot and Mouth Disease Vaccines Market report?

Ans: The Applications covered in the Foot and Mouth Disease Vaccines Market report are Cattle, Pig, Sheep & Goat, Other

What are the Type segmentation covered in the Foot and Mouth Disease Vaccines Market report?

Ans: The Types covered in the Foot and Mouth Disease Vaccines Market report are Emergency Vaccines, Conventional Vaccines

1 Foot and Mouth Disease Vaccines Market Overview
1.1 Product Definition
1.2 Foot and Mouth Disease Vaccines by Type
1.2.1 Global Foot and Mouth Disease Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Emergency Vaccines
1.2.3 Conventional Vaccines
1.3 Foot and Mouth Disease Vaccines by Application
1.3.1 Global Foot and Mouth Disease Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Cattle
1.3.3 Pig
1.3.4 Sheep & Goat
1.3.5 Other
1.4 Global Foot and Mouth Disease Vaccines Market Size Estimates and Forecasts
1.4.1 Global Foot and Mouth Disease Vaccines Revenue 2020-2031
1.4.2 Global Foot and Mouth Disease Vaccines Sales 2020-2031
1.4.3 Global Foot and Mouth Disease Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Foot and Mouth Disease Vaccines Market Competition by Manufacturers
2.1 Global Foot and Mouth Disease Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Foot and Mouth Disease Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Foot and Mouth Disease Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Foot and Mouth Disease Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Foot and Mouth Disease Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Foot and Mouth Disease Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Foot and Mouth Disease Vaccines, Date of Enter into This Industry
2.8 Global Foot and Mouth Disease Vaccines Market Competitive Situation and Trends
2.8.1 Global Foot and Mouth Disease Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Foot and Mouth Disease Vaccines Players Market Share by Revenue
2.8.3 Global Foot and Mouth Disease Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Foot and Mouth Disease Vaccines Market Scenario by Region
3.1 Global Foot and Mouth Disease Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Foot and Mouth Disease Vaccines Sales by Region: 2020-2031
3.2.1 Global Foot and Mouth Disease Vaccines Sales by Region: 2020-2025
3.2.2 Global Foot and Mouth Disease Vaccines Sales by Region: 2026-2031
3.3 Global Foot and Mouth Disease Vaccines Revenue by Region: 2020-2031
3.3.1 Global Foot and Mouth Disease Vaccines Revenue by Region: 2020-2025
3.3.2 Global Foot and Mouth Disease Vaccines Revenue by Region: 2026-2031
3.4 North America Foot and Mouth Disease Vaccines Market Facts & Figures by Country
3.4.1 North America Foot and Mouth Disease Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Foot and Mouth Disease Vaccines Sales by Country (2020-2031)
3.4.3 North America Foot and Mouth Disease Vaccines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Foot and Mouth Disease Vaccines Market Facts & Figures by Country
3.5.1 Europe Foot and Mouth Disease Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Foot and Mouth Disease Vaccines Sales by Country (2020-2031)
3.5.3 Europe Foot and Mouth Disease Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Foot and Mouth Disease Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Foot and Mouth Disease Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Foot and Mouth Disease Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Foot and Mouth Disease Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Foot and Mouth Disease Vaccines Market Facts & Figures by Country
3.7.1 Latin America Foot and Mouth Disease Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Foot and Mouth Disease Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Foot and Mouth Disease Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Foot and Mouth Disease Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Foot and Mouth Disease Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Foot and Mouth Disease Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Foot and Mouth Disease Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Foot and Mouth Disease Vaccines Sales by Type (2020-2031)
4.1.1 Global Foot and Mouth Disease Vaccines Sales by Type (2020-2025)
4.1.2 Global Foot and Mouth Disease Vaccines Sales by Type (2026-2031)
4.1.3 Global Foot and Mouth Disease Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Foot and Mouth Disease Vaccines Revenue by Type (2020-2031)
4.2.1 Global Foot and Mouth Disease Vaccines Revenue by Type (2020-2025)
4.2.2 Global Foot and Mouth Disease Vaccines Revenue by Type (2026-2031)
4.2.3 Global Foot and Mouth Disease Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Foot and Mouth Disease Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Foot and Mouth Disease Vaccines Sales by Application (2020-2031)
5.1.1 Global Foot and Mouth Disease Vaccines Sales by Application (2020-2025)
5.1.2 Global Foot and Mouth Disease Vaccines Sales by Application (2026-2031)
5.1.3 Global Foot and Mouth Disease Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Foot and Mouth Disease Vaccines Revenue by Application (2020-2031)
5.2.1 Global Foot and Mouth Disease Vaccines Revenue by Application (2020-2025)
5.2.2 Global Foot and Mouth Disease Vaccines Revenue by Application (2026-2031)
5.2.3 Global Foot and Mouth Disease Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Foot and Mouth Disease Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Jinyu Group
6.1.1 Jinyu Group Company Information
6.1.2 Jinyu Group Description and Business Overview
6.1.3 Jinyu Group Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Jinyu Group Foot and Mouth Disease Vaccines Product Portfolio
6.1.5 Jinyu Group Recent Developments/Updates
6.2 Cavet Bio
6.2.1 Cavet Bio Company Information
6.2.2 Cavet Bio Description and Business Overview
6.2.3 Cavet Bio Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cavet Bio Foot and Mouth Disease Vaccines Product Portfolio
6.2.5 Cavet Bio Recent Developments/Updates
6.3 CAHIC
6.3.1 CAHIC Company Information
6.3.2 CAHIC Description and Business Overview
6.3.3 CAHIC Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CAHIC Foot and Mouth Disease Vaccines Product Portfolio
6.3.5 CAHIC Recent Developments/Updates
6.4 Tecon Group
6.4.1 Tecon Group Company Information
6.4.2 Tecon Group Description and Business Overview
6.4.3 Tecon Group Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Tecon Group Foot and Mouth Disease Vaccines Product Portfolio
6.4.5 Tecon Group Recent Developments/Updates
6.5 Shen Lian
6.5.1 Shen Lian Company Information
6.5.2 Shen Lian Description and Business Overview
6.5.3 Shen Lian Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shen Lian Foot and Mouth Disease Vaccines Product Portfolio
6.5.5 Shen Lian Recent Developments/Updates
6.6 Biogenesis Bago
6.6.1 Biogenesis Bago Company Information
6.6.2 Biogenesis Bago Description and Business Overview
6.6.3 Biogenesis Bago Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Biogenesis Bago Foot and Mouth Disease Vaccines Product Portfolio
6.6.5 Biogenesis Bago Recent Developments/Updates
6.7 BIGVET Biotech
6.7.1 BIGVET Biotech Company Information
6.7.2 BIGVET Biotech Description and Business Overview
6.7.3 BIGVET Biotech Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BIGVET Biotech Foot and Mouth Disease Vaccines Product Portfolio
6.7.5 BIGVET Biotech Recent Developments/Updates
6.8 Indian Immunologicals
6.8.1 Indian Immunologicals Company Information
6.8.2 Indian Immunologicals Description and Business Overview
6.8.3 Indian Immunologicals Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Indian Immunologicals Foot and Mouth Disease Vaccines Product Portfolio
6.8.5 Indian Immunologicals Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Company Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Boehringer Ingelheim Foot and Mouth Disease Vaccines Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 MSD Animal Health
6.10.1 MSD Animal Health Company Information
6.10.2 MSD Animal Health Description and Business Overview
6.10.3 MSD Animal Health Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 MSD Animal Health Foot and Mouth Disease Vaccines Product Portfolio
6.10.5 MSD Animal Health Recent Developments/Updates
6.11 CEVA
6.11.1 CEVA Company Information
6.11.2 CEVA Description and Business Overview
6.11.3 CEVA Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CEVA Foot and Mouth Disease Vaccines Product Portfolio
6.11.5 CEVA Recent Developments/Updates
6.12 Bayer HealthCare
6.12.1 Bayer HealthCare Company Information
6.12.2 Bayer HealthCare Description and Business Overview
6.12.3 Bayer HealthCare Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Bayer HealthCare Foot and Mouth Disease Vaccines Product Portfolio
6.12.5 Bayer HealthCare Recent Developments/Updates
6.13 VECOL
6.13.1 VECOL Company Information
6.13.2 VECOL Description and Business Overview
6.13.3 VECOL Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 VECOL Foot and Mouth Disease Vaccines Product Portfolio
6.13.5 VECOL Recent Developments/Updates
6.14 Sanofi (Merial)
6.14.1 Sanofi (Merial) Company Information
6.14.2 Sanofi (Merial) Description and Business Overview
6.14.3 Sanofi (Merial) Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sanofi (Merial) Foot and Mouth Disease Vaccines Product Portfolio
6.14.5 Sanofi (Merial) Recent Developments/Updates
6.15 Brilliant Bio Pharma
6.15.1 Brilliant Bio Pharma Company Information
6.15.2 Brilliant Bio Pharma Description and Business Overview
6.15.3 Brilliant Bio Pharma Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Brilliant Bio Pharma Foot and Mouth Disease Vaccines Product Portfolio
6.15.5 Brilliant Bio Pharma Recent Developments/Updates
6.16 VETAL
6.16.1 VETAL Company Information
6.16.2 VETAL Description and Business Overview
6.16.3 VETAL Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.16.4 VETAL Foot and Mouth Disease Vaccines Product Portfolio
6.16.5 VETAL Recent Developments/Updates
6.17 BVI
6.17.1 BVI Company Information
6.17.2 BVI Description and Business Overview
6.17.3 BVI Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.17.4 BVI Foot and Mouth Disease Vaccines Product Portfolio
6.17.5 BVI Recent Developments/Updates
6.18 LIMOR
6.18.1 LIMOR Company Information
6.18.2 LIMOR Description and Business Overview
6.18.3 LIMOR Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.18.4 LIMOR Foot and Mouth Disease Vaccines Product Portfolio
6.18.5 LIMOR Recent Developments/Updates
6.19 ME VAC
6.19.1 ME VAC Company Information
6.19.2 ME VAC Description and Business Overview
6.19.3 ME VAC Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.19.4 ME VAC Foot and Mouth Disease Vaccines Product Portfolio
6.19.5 ME VAC Recent Developments/Updates
6.20 Agrovet
6.20.1 Agrovet Company Information
6.20.2 Agrovet Description and Business Overview
6.20.3 Agrovet Foot and Mouth Disease Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Agrovet Foot and Mouth Disease Vaccines Product Portfolio
6.20.5 Agrovet Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Foot and Mouth Disease Vaccines Industry Chain Analysis
7.2 Foot and Mouth Disease Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Foot and Mouth Disease Vaccines Production Mode & Process Analysis
7.4 Foot and Mouth Disease Vaccines Sales and Marketing
7.4.1 Foot and Mouth Disease Vaccines Sales Channels
7.4.2 Foot and Mouth Disease Vaccines Distributors
7.5 Foot and Mouth Disease Vaccines Customer Analysis
8 Foot and Mouth Disease Vaccines Market Dynamics
8.1 Foot and Mouth Disease Vaccines Industry Trends
8.2 Foot and Mouth Disease Vaccines Market Drivers
8.3 Foot and Mouth Disease Vaccines Market Challenges
8.4 Foot and Mouth Disease Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Foot and Mouth Disease Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Foot and Mouth Disease Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Foot and Mouth Disease Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Foot and Mouth Disease Vaccines Sales (K L) of Key Manufacturers (2020-2025)
 Table 5. Global Foot and Mouth Disease Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Foot and Mouth Disease Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Foot and Mouth Disease Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Foot and Mouth Disease Vaccines Average Price (USD/L) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Foot and Mouth Disease Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Foot and Mouth Disease Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Foot and Mouth Disease Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Foot and Mouth Disease Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Foot and Mouth Disease Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Foot and Mouth Disease Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Foot and Mouth Disease Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Foot and Mouth Disease Vaccines Sales by Region (2020-2025) & (K L)
 Table 18. Global Foot and Mouth Disease Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Foot and Mouth Disease Vaccines Sales by Region (2026-2031) & (K L)
 Table 20. Global Foot and Mouth Disease Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Foot and Mouth Disease Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Foot and Mouth Disease Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Foot and Mouth Disease Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Foot and Mouth Disease Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Foot and Mouth Disease Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Foot and Mouth Disease Vaccines Sales by Country (2020-2025) & (K L)
 Table 27. North America Foot and Mouth Disease Vaccines Sales by Country (2026-2031) & (K L)
 Table 28. North America Foot and Mouth Disease Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Foot and Mouth Disease Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Foot and Mouth Disease Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Foot and Mouth Disease Vaccines Sales by Country (2020-2025) & (K L)
 Table 32. Europe Foot and Mouth Disease Vaccines Sales by Country (2026-2031) & (K L)
 Table 33. Europe Foot and Mouth Disease Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Foot and Mouth Disease Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Foot and Mouth Disease Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Foot and Mouth Disease Vaccines Sales by Region (2020-2025) & (K L)
 Table 37. Asia Pacific Foot and Mouth Disease Vaccines Sales by Region (2026-2031) & (K L)
 Table 38. Asia Pacific Foot and Mouth Disease Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Foot and Mouth Disease Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Foot and Mouth Disease Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Foot and Mouth Disease Vaccines Sales by Country (2020-2025) & (K L)
 Table 42. Latin America Foot and Mouth Disease Vaccines Sales by Country (2026-2031) & (K L)
 Table 43. Latin America Foot and Mouth Disease Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Foot and Mouth Disease Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Foot and Mouth Disease Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Foot and Mouth Disease Vaccines Sales by Country (2020-2025) & (K L)
 Table 47. Middle East and Africa Foot and Mouth Disease Vaccines Sales by Country (2026-2031) & (K L)
 Table 48. Middle East and Africa Foot and Mouth Disease Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Foot and Mouth Disease Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Foot and Mouth Disease Vaccines Sales (K L) by Type (2020-2025)
 Table 51. Global Foot and Mouth Disease Vaccines Sales (K L) by Type (2026-2031)
 Table 52. Global Foot and Mouth Disease Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Foot and Mouth Disease Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Foot and Mouth Disease Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Foot and Mouth Disease Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Foot and Mouth Disease Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Foot and Mouth Disease Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Foot and Mouth Disease Vaccines Price (USD/L) by Type (2020-2025)
 Table 59. Global Foot and Mouth Disease Vaccines Price (USD/L) by Type (2026-2031)
 Table 60. Global Foot and Mouth Disease Vaccines Sales (K L) by Application (2020-2025)
 Table 61. Global Foot and Mouth Disease Vaccines Sales (K L) by Application (2026-2031)
 Table 62. Global Foot and Mouth Disease Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Foot and Mouth Disease Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Foot and Mouth Disease Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Foot and Mouth Disease Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Foot and Mouth Disease Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Foot and Mouth Disease Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Foot and Mouth Disease Vaccines Price (USD/L) by Application (2020-2025)
 Table 69. Global Foot and Mouth Disease Vaccines Price (USD/L) by Application (2026-2031)
 Table 70. Jinyu Group Company Information
 Table 71. Jinyu Group Description and Business Overview
 Table 72. Jinyu Group Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 73. Jinyu Group Foot and Mouth Disease Vaccines Product
 Table 74. Jinyu Group Recent Developments/Updates
 Table 75. Cavet Bio Company Information
 Table 76. Cavet Bio Description and Business Overview
 Table 77. Cavet Bio Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 78. Cavet Bio Foot and Mouth Disease Vaccines Product
 Table 79. Cavet Bio Recent Developments/Updates
 Table 80. CAHIC Company Information
 Table 81. CAHIC Description and Business Overview
 Table 82. CAHIC Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 83. CAHIC Foot and Mouth Disease Vaccines Product
 Table 84. CAHIC Recent Developments/Updates
 Table 85. Tecon Group Company Information
 Table 86. Tecon Group Description and Business Overview
 Table 87. Tecon Group Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 88. Tecon Group Foot and Mouth Disease Vaccines Product
 Table 89. Tecon Group Recent Developments/Updates
 Table 90. Shen Lian Company Information
 Table 91. Shen Lian Description and Business Overview
 Table 92. Shen Lian Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 93. Shen Lian Foot and Mouth Disease Vaccines Product
 Table 94. Shen Lian Recent Developments/Updates
 Table 95. Biogenesis Bago Company Information
 Table 96. Biogenesis Bago Description and Business Overview
 Table 97. Biogenesis Bago Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 98. Biogenesis Bago Foot and Mouth Disease Vaccines Product
 Table 99. Biogenesis Bago Recent Developments/Updates
 Table 100. BIGVET Biotech Company Information
 Table 101. BIGVET Biotech Description and Business Overview
 Table 102. BIGVET Biotech Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 103. BIGVET Biotech Foot and Mouth Disease Vaccines Product
 Table 104. BIGVET Biotech Recent Developments/Updates
 Table 105. Indian Immunologicals Company Information
 Table 106. Indian Immunologicals Description and Business Overview
 Table 107. Indian Immunologicals Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 108. Indian Immunologicals Foot and Mouth Disease Vaccines Product
 Table 109. Indian Immunologicals Recent Developments/Updates
 Table 110. Boehringer Ingelheim Company Information
 Table 111. Boehringer Ingelheim Description and Business Overview
 Table 112. Boehringer Ingelheim Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 113. Boehringer Ingelheim Foot and Mouth Disease Vaccines Product
 Table 114. Boehringer Ingelheim Recent Developments/Updates
 Table 115. MSD Animal Health Company Information
 Table 116. MSD Animal Health Description and Business Overview
 Table 117. MSD Animal Health Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 118. MSD Animal Health Foot and Mouth Disease Vaccines Product
 Table 119. MSD Animal Health Recent Developments/Updates
 Table 120. CEVA Company Information
 Table 121. CEVA Description and Business Overview
 Table 122. CEVA Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 123. CEVA Foot and Mouth Disease Vaccines Product
 Table 124. CEVA Recent Developments/Updates
 Table 125. Bayer HealthCare Company Information
 Table 126. Bayer HealthCare Description and Business Overview
 Table 127. Bayer HealthCare Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 128. Bayer HealthCare Foot and Mouth Disease Vaccines Product
 Table 129. Bayer HealthCare Recent Developments/Updates
 Table 130. VECOL Company Information
 Table 131. VECOL Description and Business Overview
 Table 132. VECOL Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 133. VECOL Foot and Mouth Disease Vaccines Product
 Table 134. VECOL Recent Developments/Updates
 Table 135. Sanofi (Merial) Company Information
 Table 136. Sanofi (Merial) Description and Business Overview
 Table 137. Sanofi (Merial) Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 138. Sanofi (Merial) Foot and Mouth Disease Vaccines Product
 Table 139. Sanofi (Merial) Recent Developments/Updates
 Table 140. Brilliant Bio Pharma Company Information
 Table 141. Brilliant Bio Pharma Description and Business Overview
 Table 142. Brilliant Bio Pharma Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 143. Brilliant Bio Pharma Foot and Mouth Disease Vaccines Product
 Table 144. Brilliant Bio Pharma Recent Developments/Updates
 Table 145. VETAL Company Information
 Table 146. VETAL Description and Business Overview
 Table 147. VETAL Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 148. VETAL Foot and Mouth Disease Vaccines Product
 Table 149. VETAL Recent Developments/Updates
 Table 150. BVI Company Information
 Table 151. BVI Description and Business Overview
 Table 152. BVI Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 153. BVI Foot and Mouth Disease Vaccines Product
 Table 154. BVI Recent Developments/Updates
 Table 155. LIMOR Company Information
 Table 156. LIMOR Description and Business Overview
 Table 157. LIMOR Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 158. LIMOR Foot and Mouth Disease Vaccines Product
 Table 159. LIMOR Recent Developments/Updates
 Table 160. ME VAC Company Information
 Table 161. ME VAC Description and Business Overview
 Table 162. ME VAC Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 163. ME VAC Foot and Mouth Disease Vaccines Product
 Table 164. ME VAC Recent Developments/Updates
 Table 165. Agrovet Company Information
 Table 166. Agrovet Description and Business Overview
 Table 167. Agrovet Foot and Mouth Disease Vaccines Sales (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2020-2025)
 Table 168. Agrovet Foot and Mouth Disease Vaccines Product
 Table 169. Agrovet Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Foot and Mouth Disease Vaccines Distributors List
 Table 173. Foot and Mouth Disease Vaccines Customers List
 Table 174. Foot and Mouth Disease Vaccines Market Trends
 Table 175. Foot and Mouth Disease Vaccines Market Drivers
 Table 176. Foot and Mouth Disease Vaccines Market Challenges
 Table 177. Foot and Mouth Disease Vaccines Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Foot and Mouth Disease Vaccines
 Figure 2. Global Foot and Mouth Disease Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Foot and Mouth Disease Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Emergency Vaccines Product Picture
 Figure 5. Conventional Vaccines Product Picture
 Figure 6. Global Foot and Mouth Disease Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Foot and Mouth Disease Vaccines Market Share by Application: 2024 & 2031
 Figure 8. Cattle
 Figure 9. Pig
 Figure 10. Sheep & Goat
 Figure 11. Other
 Figure 12. Global Foot and Mouth Disease Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Foot and Mouth Disease Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Foot and Mouth Disease Vaccines Sales (2020-2031) & (K L)
 Figure 15. Global Foot and Mouth Disease Vaccines Average Price (USD/L) & (2020-2031)
 Figure 16. Foot and Mouth Disease Vaccines Report Years Considered
 Figure 17. Foot and Mouth Disease Vaccines Sales Share by Manufacturers in 2024
 Figure 18. Global Foot and Mouth Disease Vaccines Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Foot and Mouth Disease Vaccines Players: Market Share by Revenue in Foot and Mouth Disease Vaccines in 2024
 Figure 20. Foot and Mouth Disease Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Foot and Mouth Disease Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Foot and Mouth Disease Vaccines Sales Market Share by Country (2020-2031)
 Figure 23. North America Foot and Mouth Disease Vaccines Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Foot and Mouth Disease Vaccines Sales Market Share by Country (2020-2031)
 Figure 27. Europe Foot and Mouth Disease Vaccines Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Foot and Mouth Disease Vaccines Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Foot and Mouth Disease Vaccines Revenue Market Share by Region (2020-2031)
 Figure 35. China Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Foot and Mouth Disease Vaccines Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Foot and Mouth Disease Vaccines Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Foot and Mouth Disease Vaccines Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Foot and Mouth Disease Vaccines Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Foot and Mouth Disease Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Foot and Mouth Disease Vaccines by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Foot and Mouth Disease Vaccines by Type (2020-2031)
 Figure 57. Global Foot and Mouth Disease Vaccines Price (USD/L) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Foot and Mouth Disease Vaccines by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Foot and Mouth Disease Vaccines by Application (2020-2031)
 Figure 60. Global Foot and Mouth Disease Vaccines Price (USD/L) by Application (2020-2031)
 Figure 61. Foot and Mouth Disease Vaccines Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners